Clinical Trial Update: Glycyrrhetinic Acid Combined With Dexamethasone in Management of Newly Diagnosed ITP [Phase 4]

View source ↗

Summary

Phase 4 trial update on glycyrrhetinic acid combined with dexamethasone for newly diagnosed immune thrombocytopenia (ITP).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Immune Thrombocytopenia

Drugs mentioned

• DEXAMETHASONE (Dexamethasone)
• Glycyrrhetinic acid (glycyrrhetinic acid)

Snippet

Sponsor: Shandong University | Conditions: Immune Thrombocytopenia | Phase 4 | Status: UNKNOWN